Delivery Order SPE2DB20D2104-SPE2DB21FQ82G
- Not listed
- This federal contract award is for a Prime Vendor Pharmaceutical Branch in Philadelphia between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,493.74 Firm Fixed Price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive...
- This federal contract award is for a Prime Vendor Pharmaceutical Branch-Philadelphia delivery order valued at $4,632.00, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a performance period through May 20, 2021 and is a firm fixed price delivery order. Amerisourcebergen, through its parent company Cencora, Inc., holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for a Prime Vendor Pharmaceutical delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,139.40 delivery order is a firm-fixed-price contract that supports the DLA Troop Support Medical program. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is a delivery order worth $3,462.33 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for providing a prime vendor pharmaceutical support to the DLA Troop Support Medical branch in Philadelphia, Pennsylvania. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a Prime Vendor Pharmacy Branch-Philadelphia contract. The $1,221.61 delivery order contract has a firm fixed price and covers the supply of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. This award is a delivery order...
- This federal contract award is for a pharmaceutical prime vendor delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA). The $1,490.55 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the provision of a prime vendor pharmaceutical branch in Philadelphia for the Defense Logistics Agency (DLA). The $11,636.45 delivery order contract has a firm fixed price and runs through November 2020. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a...
- This federal contract award is for a pharmaceutical prime vendor supply agreement between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,876.68 delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen) to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran...
- This federal contract award is for a pharmaceutical prime vendor agreement between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,099.75 delivery order supports the DLA Troop Support Medical program, providing a wide range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract covers an...
- This federal contract award is for a prime vendor pharmaceutical contract from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $1,655.24 fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC, which runs through November 2026, enables the efficient procurement of a comprehensive range of...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB21FQ82GDelivery Order
This federal contract award is for a Prime Vendor Pharmaceutical Branch-Philadelphia delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,943.80 firm fixed-price contract is a child award under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract covers the delivery of various medications, vaccines, and medical commodities such as specialty drugs, brand-name and generic pharmaceuticals, syringes, vials, and test kits. This delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen, as a subsidiary of the parent company Cencora, Inc., is well-positioned to meet the DLA's critical pharmaceutical and medical supply needs for the U.S. military and federal healthcare beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 10/26/20 |